|
All LTs (n = 86)
|
PRHK (n = 54)
|
no PRHK (n = 32)
|
P
|
---|
Age (years)
|
49.6 ± 10.9
|
48.9 ± 11.5
|
50.9 ± 9.7
|
0.400
|
Male (n)
|
59 (68.6%)
|
38 (70.4%)
|
21 (65.6%)
|
0.647
|
Height (cm)
|
170 (163–175)
|
171 (165–175)
|
170 (161–175)
|
0.922
|
Weight (cm)
|
65.8 ± 14.7
|
65.8 ± 14.1
|
65.7 ± 16.1
|
0.974
|
Child–Pugh score
|
9.0 (6.0–11.0)
|
8.5 (6.0–11.0)
|
10.5 (7.0–11.8)
|
0.081
|
MELD score
|
15.0 (9.0–19.0)
|
14.0 (9.0–17.3)
|
16.5 (9.3–19.8)
|
0.312
|
Primary diagnosis (n)
|
Hepatitis B
|
43 (50.0%)
|
22 (40.7%)
|
21 (65.6%)
|
0.026
|
Hepatitis C
|
3 (3.5%)
|
1 (1.9%)
|
2 (6.3%)
|
0.553
|
Alcoholic
|
11 (12.8%)
|
4 (7.4%)
|
7 (21.9%)
|
0.091
|
Cholestatic
|
11 (12.8%)
|
6 (11.1%)
|
5 (15.6%)
|
0.740
|
Cryptogenic
|
2 (2.3%)
|
1 (1.9%)
|
1 (3.1%)
|
1.000
|
Others
|
16 (18.6%)
|
7 (13.0%)
|
9 (28.1%)
|
0.081
|
Combined HCC
|
25 (29.1%)
|
14 (25.9%)
|
11 (34.4%)
|
0.404
|
Graft weight (g)
|
1302.9 ± 270.5
|
1362.7 ± 251.4
|
1201.9 ± 275.4
|
0.007
|
GRWR (%)
|
1.94 (1.61–2.43)
|
1.98 (1.79–2.45)
|
1.63 (1.43–2.28)
|
0.045
|
CIT (min)
|
520 (386–618)
|
549 (384–623)
|
501 (393–601)
|
0.381
|
WIT (min)
|
39.5 ± 6.8
|
38.6 ± 5.5
|
41.0 ± 8.4
|
0.143
|
IVC clamping time (min)
|
34 (31–40)
|
35 (32–38)
|
33 (30–40)
|
0.597
|
Anhepatic phase (min)
|
43 (38–49)
|
43 (37–48)
|
43 (39–49)
|
0.380
|
sK+0 (mmol/L)
|
4.17 ± 0.55
|
4.27 ± 0.56
|
4.00 ± 0.49
|
0.030
|
eK+ (mmol/L)
|
6.65 (5.38–9.73)
|
7.65 (5.68–12.20)
|
5.90 (4.40–6.88)
|
0.003
|
ECD graft (n)
|
13 (16.3%)
|
13 (24.1%)
|
1 (3.1)
|
0.011
|
- Data are presented as mean and standard deviation (SD), median (interquartile range), or n (%). LT: Liver transplantation, PRHK: postreperfusion hyperkalemia, MELD: Model for End-Stage Liver Disease, HCC: hepatocellular carcinoma, GRWR: graft-to-recipient weight ratio, CIT: cold ischemia time, WIT: warm ischemia time, IVC: inferior vena cava, sK+0: serum potassium concentration before reperfusion, eK+: effluent potassium concentration, ECD: expanded criteria donor